Nummular headache: an update and future prospects
| Autor: | María L. Cuadrado, Pedro López-Ruiz, Ángel L Guerrero |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Gabapentin Injections Subcutaneous 03 medical and health sciences 0302 clinical medicine Primary headache medicine Humans Pharmacology (medical) 030212 general & internal medicine Botulinum Toxins Type A Injections subcutaneous Headache diagnosis Analgesics Scalp Headache epidemiology business.industry General Neuroscience Chronic pain Headache medicine.disease Dermatology medicine.anatomical_structure Neuromuscular Agents Neurology (clinical) Chronic Pain business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Expert review of neurotherapeutics. 18(1) |
| ISSN: | 1744-8360 |
| Popis: | Nummular headache (NH) is characterized by continuous or intermittent head pain, which remains confined to a round or oval shaped area of the scalp, generally 1 to 6 cm in diameter. Usually mild or moderate in intensity, some patients suffer severe acute exacerbations or continuous disabling pain. Areas covered: This article reviews epidemiological and clinical features of NH, the most recently proposed pathophysiological mechanisms, and state-of-the-art management according to the literature. Expert commentary: Information regarding true incidence and prevalence is lacking, but NH is a fairly common disorder in patients attending a headache clinic. Diagnostic work-up requires the exclusion of systemic and structural disease by a thorough physical examination, blood tests including immunology screening, and neuroimaging. No clinical trials have been conducted for NH, so the level of evidence for any treatment is low. Gabapentin seems to be the most effective oral medication; subcutaneous injection of the area with onabotulinum toxin type A also seems to be effective, and should be considered as an alternative to gabapentin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|